| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH)
DCPH Technical Analysis
4
| As on 9th Jun 2023 DCPH STOCK Price closed @ 14.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 12.53 & Strong Buy for SHORT-TERM with Stoploss of 8.70 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DCPHSTOCK Price
| Open | 13.99 | Change | Price | % |
| High | 14.10 | 1 Day | 0.04 | 0.29 |
| Low | 13.67 | 1 Week | 0.52 | 3.85 |
| Close | 14.02 | 1 Month | -0.19 | -1.34 |
| Volume | 462210 | 1 Year | 3.70 | 35.85 |
| 52 Week High 22.10 | 52 Week Low 6.87 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DCPH Daily Charts |
DCPH Intraday Charts |
Whats New @ Bazaartrend |
DCPH Free Analysis |
|
|
DCPH Important Levels Intraday
| RESISTANCE | 14.85 |
| RESISTANCE | 14.58 |
| RESISTANCE | 14.42 |
| RESISTANCE | 14.25 |
| SUPPORT | 13.79 |
| SUPPORT | 13.62 |
| SUPPORT | 13.46 |
| SUPPORT | 13.19 |
DCPH Forecast May 2024
| 4th UP Forecast | 18.95 |
| 3rd UP Forecast | 17.37 |
| 2nd UP Forecast | 16.39 |
| 1st UP Forecast | 15.42 |
| 1st DOWN Forecast | 12.62 |
| 2nd DOWN Forecast | 11.65 |
| 3rd DOWN Forecast | 10.67 |
| 4th DOWN Forecast | 9.09 |
DCPH Weekly Forecast
| 4th UP Forecast | 18.36 |
| 3rd UP Forecast | 16.97 |
| 2nd UP Forecast | 16.11 |
| 1st UP Forecast | 15.25 |
| 1st DOWN Forecast | 12.79 |
| 2nd DOWN Forecast | 11.93 |
| 3rd DOWN Forecast | 11.07 |
| 4th DOWN Forecast | 9.68 |
DCPH Forecast2024
| 4th UP Forecast | 45.33 |
| 3rd UP Forecast | 35.29 |
| 2nd UP Forecast | 29.08 |
| 1st UP Forecast | 22.88 |
| 1st DOWN Forecast | 5.16 |
| 2nd DOWN Forecast | -1.04 |
| 3rd DOWN Forecast | -7.25 |
| 4th DOWN Forecast | -17.29 |
Deciphera Pharmaceuticals Inc ( NASDAQ USA Symbol : DCPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DCPH Business Profile
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing immunokinase inhibitors comprising vimseltinib (DCC-3014) that is in Phase 1b/2 clinical trial for the treatment of tenosynovial giant cell tumors; and Rebastinib, which is in Phase 1b/2 clinical trial to treat metastatic solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. In addition, it is developing DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. The company serves in the United States and Europe. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Address: 200 Smith Street, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service